BioMendics, LLC
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase II, Placebo Controlled, Clinical Trial of Topical TolaSure Targeting Aggregated Mutant Keratin in Epidermolysis Bullosa Simplex (NCT07027345) | BioMendics, LLC | 2025-09-11 |
| Safety and Efficacy of Topical TolaSure Targeting Aggregated Mutant Keratin in Severe Epidermolysis Bullosa Simplex (NCT05062070) | BioMendics, LLC | 2022-05-05 |
| Efficacy of Topical TolaSure on Acute Induced Wounds in Healthy Participants (NCT04088357) | BioMendics, LLC | 2019-08-26 |
| Safety and Efficacy of Topical TolaSure on Skin Punch Biopsies in Healthy Participants (NCT03620175) | BioMendics, LLC | 2018-07-16 |
Track BioMendics, LLC automatically
Every clearance here is in the API, with alerts when new ones post.